Who owns Applied Therapeutics Inc?
- Ticker: APLT
- CUSIP Number: 03828a101
Tip: Access positions for across all investors
Analyze quarterly positions in Applied Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Applied Therapeutics stock
Who bought or sold Applied Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Alyeska Investment Group | 10M | $34M | -14% | Dec 2023 |
|
| Franklin Resources | 7.0M | $24M | -12% | Dec 2023 |
|
| VR Adviser | 6.3M | $21M | 10% | Dec 2023 |
|
| Knoll Capital Management | 5.5M | $18M | 6% | Dec 2023 |
|
| Propel Bio Management | 5.4M | $18M | 100% | Dec 2023 |
|
| Perceptive Advisors | 4.6M | $4.6M | 100% | Dec 2023 |
|
| Vanguard Group | 3.2M | $11M | 126% | Dec 2023 |
|
| Simplify Asset Management | 2.4M | $8.1M | 0% | Dec 2023 |
|
| Henderson Group | 2.1M | $7.2M | 100% | Dec 2023 |
|
| Logos Global Management | 1.7M | $5.6M | 100% | Dec 2023 |
|
| AIGH Capital Management | 1.7M | $5.6M | 109% | Dec 2023 |
|
| Opaleye Management | 1.1M | $3.7M | 22% | Dec 2023 |
|
| Millennium Management | 600k | $2.0M | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 492k | $1.6M | 7% | Dec 2023 |
|
| Point72 Asset Management | 475k | $1.6M | 0% | Dec 2023 |
|
| Soleus Capital Management | 461k | $1.5M | -61% | Dec 2023 |
|
| Laurion Capital Management | 431k | $1.4M | 25% | Dec 2023 |
|
| Worth Venture Partners | 413k | $1.4M | 113% | Dec 2023 |
|
| Two Sigma Investments | 286k | $958k | 312% | Dec 2023 |
|
| Marshall Wace | 258k | $865k | 100% | Dec 2023 |
|
| Citigroup | 220k | $737k | 233% | Dec 2023 |
|
| Man Group | 167k | $558k | 100% | Dec 2023 |
|
| Citadel Advisors | 156k | $523k | 404% | Dec 2023 |
|
| Jane Street | 132k | $442k | -35% | Dec 2023 |
|
| Richmond Brothers | 124k | $414k | 0% | Dec 2023 |
|
| UBS Group | 120k | $403k | 11% | Dec 2023 |
|
| LMR Partners | 120k | $400k | 100% | Dec 2023 |
|
| 683 Capital Management | 101k | $338k | 100% | Dec 2023 |
|
| Simplex Trading | 72k | $241k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 59k | $196k | 1199% | Dec 2023 |
|
| Two Sigma Advisers | 51k | $171k | 227% | Dec 2023 |
|
| Maven Securities | 50k | $168k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 47k | $157k | 11996% | Dec 2023 |
|
| Bank of America Corporation | 45k | $150k | 19475% | Dec 2023 |
|
| Wealthtrust Axiom | 43k | $144k | 0% | Dec 2023 |
|
| Relyea Zuckerberg Hanson | 40k | $134k | 0% | Dec 2023 |
|
| Wolverine Trading | 33k | $111k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 27k | $90k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 25k | $82k | 0% | Dec 2023 |
|
| Jump Financial | 24k | $81k | 100% | Dec 2023 |
|
| Two Sigma Securities | 19k | $63k | 100% | Dec 2023 |
|
| Us Bancorp | 18k | $61k | 0% | Dec 2023 |
|
| Walleye Trading Advisors | 17k | $57k | -88% | Dec 2023 |
|
| Goldman Sachs Group | 17k | $56k | 100% | Dec 2023 |
|
| Squarepoint Ops | 14k | $47k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 14k | $45k | 0% | Dec 2023 |
|
| Balyasny Asset Management | 11k | $36k | 100% | Dec 2023 |
|
| Vontobel Holding | 10k | $34k | 100% | Dec 2023 |
|
| Essex Financial Services | 10k | $34k | 0% | Dec 2023 |
|
| Point72 Asia | 2.9k | $9.7k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 2.1k | $7.0k | 2511% | Dec 2023 |
|
| Rhumbline Advisers | 544.00 | $1.8k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 428.00 | $1.4k | -15% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 1.00 | $3.000000 | -100% | Dec 2023 |
|
Who sold out of Applied Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Sep 2023 | 12k | $29k |